Skip to main content

Table 2 Summary of Adverse Events

From: Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study

Adverse Events

Amlodipine/Losartan

(N = 73)

Amlodipine

(N = 75)

p-value

 

n (%)

[number of reported AEs]

n (%)

[number of reported AEs]

 

Treatment-Emergent Adverse Events

23 (31.5)

[44]

24 (32.0)

[42]

0.9486(a)

 

Mild

20 (27.4)

[41]

21 (28.0)

[39]

1.0000(b)

Severity

Moderate

3 (4.1)

[3]

2 (2.7)

[2]

ns

 

Severe

0

[0]

1 (1.3)

[1]

 

Drug-related AE

8 (11.0)

[14]

13 (17.3)

[20]

0.2665(a)

Serious AE

2 (2.7)

[2]

1 (1.3)

[1]

0.6173(b)

AE which causes rule-out

2 (2.7)

[2]

0

[0]

0.2416(b)

Death

0

[0]

0

[0]

 
  1. (a) Pearson's chi-square test
  2. (b) Fisher's exact test